For the past year IntelliPharmaCeutics International Inc.’s stock price has smaller growth than Melinta Therapeutics Inc. Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada.
